CENTRAL TRUST Co Raises Stake in GE HealthCare Technologies Inc. $GEHC

CENTRAL TRUST Co lifted its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 58.7% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 18,396 shares of the company’s stock after acquiring an additional 6,805 shares during the period. CENTRAL TRUST Co’s holdings in GE HealthCare Technologies were worth $1,382,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also recently modified their holdings of GEHC. Allianz SE raised its stake in GE HealthCare Technologies by 165.2% during the second quarter. Allianz SE now owns 350 shares of the company’s stock worth $26,000 after purchasing an additional 218 shares during the period. E Fund Management Hong Kong Co. Ltd. raised its position in shares of GE HealthCare Technologies by 130.7% during the 3rd quarter. E Fund Management Hong Kong Co. Ltd. now owns 346 shares of the company’s stock valued at $26,000 after buying an additional 196 shares during the period. Godsey & Gibb Inc. acquired a new position in GE HealthCare Technologies in the third quarter valued at approximately $26,000. Oakworth Capital Inc. grew its position in GE HealthCare Technologies by 1,876.2% in the third quarter. Oakworth Capital Inc. now owns 415 shares of the company’s stock worth $31,000 after acquiring an additional 394 shares during the period. Finally, Gladwyn Financial Advisors Inc. purchased a new position in GE HealthCare Technologies in the second quarter worth approximately $34,000. Institutional investors and hedge funds own 82.06% of the company’s stock.

GE HealthCare Technologies Stock Up 2.1%

Shares of GEHC opened at $80.34 on Friday. The stock has a market capitalization of $36.61 billion, a PE ratio of 17.62, a P/E/G ratio of 1.77 and a beta of 1.08. GE HealthCare Technologies Inc. has a 1 year low of $57.65 and a 1 year high of $93.26. The company has a debt-to-equity ratio of 0.91, a quick ratio of 1.13 and a current ratio of 1.37. The company’s 50-day simple moving average is $82.44 and its 200-day simple moving average is $77.62.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings data on Wednesday, February 4th. The company reported $1.44 earnings per share for the quarter, beating analysts’ consensus estimates of $1.40 by $0.04. The firm had revenue of $5.70 billion during the quarter, compared to analysts’ expectations of $5.60 billion. GE HealthCare Technologies had a net margin of 10.11% and a return on equity of 21.35%. The business’s quarterly revenue was up 7.1% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.45 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. Analysts forecast that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Investors of record on Friday, April 3rd will be issued a $0.035 dividend. The ex-dividend date is Thursday, April 2nd. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio (DPR) is 3.07%.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on GEHC shares. Citigroup upped their price target on GE HealthCare Technologies from $83.00 to $88.00 and gave the company a “neutral” rating in a research note on Thursday, December 11th. Wells Fargo & Company upped their target price on shares of GE HealthCare Technologies from $95.00 to $97.00 and gave the company an “overweight” rating in a research report on Thursday, February 5th. Evercore lifted their price target on shares of GE HealthCare Technologies from $95.00 to $98.00 and gave the company an “outperform” rating in a research report on Thursday, February 5th. Bank of America boosted their price target on shares of GE HealthCare Technologies from $82.00 to $92.00 and gave the company a “neutral” rating in a research note on Monday, January 5th. Finally, Barclays increased their price objective on shares of GE HealthCare Technologies from $86.00 to $87.00 and gave the stock an “equal weight” rating in a research report on Friday, February 6th. Seven analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $92.50.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.